Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,404 | N/A | -216,807 | -152,598 | -35,558 |
| Depreciation Amortization | 817 | N/A | 1,655 | 1,010 | 388 |
| Other Working Capital | 20,141 | N/A | 14,097 | 10,456 | 884 |
| Other Operating Activity | 11,769 | 0 | 81,756 | 71,485 | 2,110 |
| Operating Cash Flow | $-54,677 | $N/A | $-119,299 | $-69,647 | $-32,176 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 73,833 | 52,150 | 26,881 |
| PPE Investments | -2,064 | N/A | -11,169 | -7,985 | -2,940 |
| Purchase Of Investment | N/A | N/A | N/A | -135 | -135 |
| Investing Cash Flow | $-2,064 | $N/A | $62,664 | $44,030 | $23,806 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 182,216 | N/A | 182,217 |
| Debt Repayment | N/A | N/A | N/A | 182,216 | N/A |
| Common Stock Issued | N/A | N/A | 395,376 | 368,847 | 73,367 |
| Other Financing Activity | 1,825 | 0 | 55 | 26,275 | -1,475 |
| Financing Cash Flow | $1,825 | $N/A | $577,647 | $577,338 | $254,109 |
| Exchange Rate Effect | -9 | N/A | -65 | -99 | 47 |
| Beginning Cash Position | 494,173 | N/A | 60,960 | 60,960 | 60,960 |
| End Cash Position | 439,248 | N/A | 581,907 | 612,582 | 306,746 |
| Net Cash Flow | $-54,925 | $N/A | $520,947 | $551,622 | $245,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,677 | N/A | -119,299 | -69,647 | -32,176 |
| Capital Expenditure | -2,064 | N/A | -11,169 | -7,985 | -2,940 |
| Free Cash Flow | -56,741 | 0 | -130,468 | -77,632 | -35,116 |